Regarding the tumor infiltrating lymphocytes (TILs) compartment (Figure S2A), PeptiCRAd and PeptiCRAd+ DAC, despite a lower CD4+ T cell infiltration (Figure 4C), showed a reduced percentage of intratumoral Tregs (CD25+, FOXP3+) (Figure 4D). This evidence concerns the gene FOXP3 and neoplasm.